Log in

NYSE:LLYEli Lilly And Co News Headlines

$152.95
+2.30 (+1.53 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$149.94
Now: $152.95
$153.64
50-Day Range
$144.42
MA: $154.21
$162.93
52-Week Range
$101.36
Now: $152.95
$164.90
Volume9.47 million shs
Average Volume4.32 million shs
Market Capitalization$146.29 billion
P/E Ratio25.28
Dividend Yield1.96%
Beta0.25

Headlines

Eli Lilly And Co (NYSE LLY) News Headlines

Source:
DateHeadline
Lillys CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung CancerLilly's CYRAMZA® (ramucirumab) Receives FDA Approval as First-Line Treatment for Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
www.prnewswire.com - May 29 at 9:39 PM
Lilly Cleared by FDA to Market Alzheimers Detection DrugLilly Cleared by FDA to Market Alzheimer's Detection Drug
finance.yahoo.com - May 29 at 2:35 PM
FDA Okays Lillys Alzheimers Disease Diagnostic Agent TauvidFDA Okays Lilly's Alzheimer's Disease Diagnostic Agent Tauvid
finance.yahoo.com - May 29 at 2:35 PM
Diabetes Care Drugs Market Precise Outlook 2024- Novo Nordisk, Sanofi, Eli Lilly, Takeda, Pfizer, Janssen Pharmaceuticals, AstellasDiabetes Care Drugs Market Precise Outlook 2024- Novo Nordisk, Sanofi, Eli Lilly, Takeda, Pfizer, Janssen Pharmaceuticals, Astellas
www.marketwatch.com - May 29 at 9:35 AM
Lilly gets FDA approval for Alzheimers diagnostic agentLilly gets FDA approval for Alzheimer's diagnostic agent
finance.yahoo.com - May 29 at 9:35 AM
Veeva Systems (VEEV) Q1 Earnings and Revenues Beat EstimatesVeeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates
finance.yahoo.com - May 29 at 9:35 AM
U.S. FDA approves Eli Lillys diagnostic agent for Alzheimers diseaseU.S. FDA approves Eli Lilly's diagnostic agent for Alzheimer's disease
www.reuters.com - May 28 at 10:22 PM
Eli Lilly Earns Landmark Approval for Alzheimers Disease Imaging AgentEli Lilly Earns Landmark Approval for Alzheimer's Disease Imaging Agent
finance.yahoo.com - May 28 at 10:22 PM
3 Investing Facts About Required Minimum Distributions You Need to Know - May 28, 20203 Investing Facts About Required Minimum Distributions You Need to Know - May 28, 2020
finance.yahoo.com - May 28 at 12:22 PM
Insulin Market Report 2020: Includes Revenue Data (2013-2022) for Novo Nordisk, Sanofi Aventis, Eli Lilly, Merck & Co, and Beckton DickinsonInsulin Market Report 2020: Includes Revenue Data (2013-2022) for Novo Nordisk, Sanofi Aventis, Eli Lilly, Merck & Co, and Beckton Dickinson
www.prnewswire.com - May 27 at 3:19 PM
White House announces plan for Medicare enrollees to get insulin for $35 a monthWhite House announces plan for Medicare enrollees to get insulin for $35 a month
finance.yahoo.com - May 27 at 9:46 AM
Eli Lilly Shares Cross 2% Yield MarkEli Lilly Shares Cross 2% Yield Mark
www.nasdaq.com - May 26 at 6:23 PM
CanSino Biologics Covid-19 Vaccine Shows Early PromiseCanSino Biologics' Covid-19 Vaccine Shows Early Promise
finance.yahoo.com - May 26 at 6:23 PM
Statement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings ModelStatement from Lilly Chairman and CEO Dave Ricks on New Part D Senior Savings Model
finance.yahoo.com - May 26 at 6:23 PM
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining empagliflozin’s effects following an acute myocardial ...Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining empagliflozin’s effects following an acute myocardial ...
www.businesswire.com - May 26 at 1:21 PM
BRIEF-Boehringer Ingelheim and Lilly To Collaborate With Duke Clinical Research Institute On A Pragmatic TrialBRIEF-Boehringer Ingelheim and Lilly To Collaborate With Duke Clinical Research Institute On A Pragmatic Trial
www.reuters.com - May 26 at 1:21 PM
Nature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing AntibodiesNature Publishes Preclinical Characterization and Primate Efficacy Data on Junshi Biosciences’ COVID-19 Neutralizing Antibodies
finance.yahoo.com - May 26 at 1:21 PM
Lilly, Junshi Biosciences plan to start human trials of COVID-19 antibody in Q2Lilly, Junshi Biosciences plan to start human trials of COVID-19 antibody in Q2
finance.yahoo.com - May 26 at 1:21 PM
Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2Eli Lilly, Junshi Biosciences To Start Human Testing Of Covid-19 Antibodies By Q2
finance.yahoo.com - May 26 at 1:21 PM
Emgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment FailureEmgality® Shows Improvement in Work Productivity and Health and Well-Being Between Attacks in Patients with Migraine and a History of Preventive Treatment Failure
finance.yahoo.com - May 26 at 8:20 AM
Boehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarctionBoehringer Ingelheim and Lilly to collaborate with Duke Clinical Research Institute on a pragmatic trial examining Jardiance's® effects following an acute myocardial infarction
finance.yahoo.com - May 26 at 8:20 AM
Antidiabetics Market 2015 In Deep Analysis, Expert Reviews and Healthcare Outlook 2027; Merck & Co. Inc, Shenzhen Kexing, Sanofi-AventisAntidiabetics Market 2015 In Deep Analysis, Expert Reviews and Healthcare Outlook 2027; Merck & Co. Inc, Shenzhen Kexing, Sanofi-Aventis
www.marketwatch.com - May 25 at 1:48 PM
Peptide Therapeutics Market Expected to Grow at CAGR of 8.2% by 2023|Pfizer Inc., Novo Nordisk, Eli Lilly and CompanyPeptide Therapeutics Market Expected to Grow at CAGR of 8.2% by 2023|Pfizer Inc., Novo Nordisk, Eli Lilly and Company
www.marketwatch.com - May 25 at 1:48 PM
Why Is Lilly (LLY) Down 5.5% Since Last Earnings Report?Why Is Lilly (LLY) Down 5.5% Since Last Earnings Report?
finance.yahoo.com - May 23 at 5:07 PM
Short Interest in Eli Lilly And Co (NYSE:LLY) Drops By 9.5%Short Interest in Eli Lilly And Co (NYSE:LLY) Drops By 9.5%
www.americanbankingnews.com - May 22 at 12:14 AM
How Eli Lilly’s Investors Cashed In 90% Capital Gains While Sales Barely Moved?How Eli Lilly’s Investors Cashed In 90% Capital Gains While Sales Barely Moved?
www.forbes.com - May 21 at 12:34 PM
CanSino’s 23% Stock Slump Shows Perils of Chasing Vaccine HypeCanSino’s 23% Stock Slump Shows Perils of Chasing Vaccine Hype
finance.yahoo.com - May 21 at 12:34 PM
Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year?
finance.yahoo.com - May 21 at 12:34 PM
Animal Antibiotics and Antimicrobials Market to See Huge Growth by 2025 | Eli Lilly and Company , Bayer AG, VirbacAnimal Antibiotics and Antimicrobials Market to See Huge Growth by 2025 | Eli Lilly and Company , Bayer AG, Virbac
www.marketwatch.com - May 21 at 7:33 AM
Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?Does Eli Lilly (NYSE:LLY) Deserve A Spot On Your Watchlist?
finance.yahoo.com - May 21 at 7:33 AM
BRIEF-Eli Lilly - Study Results Demonstrate Societal Cost Burden During Early Stages Of Alzheimers DiseaseBRIEF-Eli Lilly - Study Results Demonstrate Societal Cost Burden During Early Stages Of Alzheimer's Disease
www.reuters.com - May 21 at 2:05 AM
Eli Lilly Reports Results Of GERAS-US Study - Quick FactsEli Lilly Reports Results Of GERAS-US Study - Quick Facts
www.nasdaq.com - May 19 at 2:17 PM
AstraZeneca's Enhertu Gets Breakthrough Therapy Tag for NSCLCAstraZeneca's Enhertu Gets Breakthrough Therapy Tag for NSCLC
finance.yahoo.com - May 19 at 2:17 PM
Results of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's DiseaseResults of GERAS-US Study Demonstrate Societal Cost Burden for Patients and Caregivers During Early Stages of Alzheimer's Disease
finance.yahoo.com - May 19 at 9:16 AM
3 Market-Beating Dividend Stocks to Buy Today3 Market-Beating Dividend Stocks to Buy Today
finance.yahoo.com - May 18 at 2:52 PM
Biotechs harness AI in battle against Covid-19Biotechs harness AI in battle against Covid-19
finance.yahoo.com - May 15 at 12:06 AM
TYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell CarcinomaTYVYT® (Sintilimab Injection) ORIENT-2 Study Met its Primary Endpoint of Overall Survival in the Second-Line Treatment of Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma
finance.yahoo.com - May 13 at 11:03 PM
Drug Sector Highly Resilient Amid Coronavirus Mayhem: 5 PicksDrug Sector Highly Resilient Amid Coronavirus Mayhem: 5 Picks
finance.yahoo.com - May 13 at 1:01 PM
HMS Holdings (HMSY) Earnings and Revenues Beat Estimates in Q1HMS Holdings (HMSY) Earnings and Revenues Beat Estimates in Q1
finance.yahoo.com - May 13 at 1:01 PM
Phibro (PAHC) Q3 Earnings Surpass Estimates, Margin DeclinesPhibro (PAHC) Q3 Earnings Surpass Estimates, Margin Declines
finance.yahoo.com - May 13 at 1:01 PM
Global Vascular Endothelial Growth Factor B Market Assessing Major Growth Opportunities | Alteogen Inc, CSL Ltd, Eli Lilly and CompanyGlobal Vascular Endothelial Growth Factor B Market Assessing Major Growth Opportunities | Alteogen Inc, CSL Ltd, Eli Lilly and Company
www.marketwatch.com - May 13 at 1:30 AM
National Vision (EYE) Q1 Earnings Top Estimates, Margin FallsNational Vision (EYE) Q1 Earnings Top Estimates, Margin Falls
finance.yahoo.com - May 12 at 3:29 PM
Allscripts (MDRX) Q1 Earnings and Revenues Miss EstimatesAllscripts (MDRX) Q1 Earnings and Revenues Miss Estimates
finance.yahoo.com - May 12 at 3:29 PM
Chinas Junshi Bio, Lilly to Co-Develop Covid-19 Antibody TherapiesChina's Junshi Bio, Lilly to Co-Develop Covid-19 Antibody Therapies
finance.yahoo.com - May 12 at 3:47 AM
Cluster Headache Syndrome Drug Market 2020 Analysis and Precise Outlook: Center Laboratories Inc, Eli Lilly and Company, Novartis AGCluster Headache Syndrome Drug Market 2020 Analysis and Precise Outlook: Center Laboratories Inc, Eli Lilly and Company, Novartis AG
www.marketwatch.com - May 11 at 10:47 PM
Metabotropic Glutamate Receptor 2 Market 2020-2027: Eli Lilly and Company,Johnson & Johnson, Merck & Co IncMetabotropic Glutamate Receptor 2 Market 2020-2027: Eli Lilly and Company,Johnson & Johnson, Merck & Co Inc
www.marketwatch.com - May 11 at 10:47 PM
Eli Lillys Retevmo, And Other News: The Good, Bad And Ugly Of BiopharmaEli Lilly's Retevmo, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - May 11 at 5:47 PM
Eli Lilly, with big expansion plans in Durham, buys 110 acresEli Lilly, with big expansion plans in Durham, buys 110 acres
www.bizjournals.com - May 11 at 5:47 PM
A Triangle Formation on Drug Maker Eli Lilly Is Ready for an Upside BreakoutA Triangle Formation on Drug Maker Eli Lilly Is Ready for an Upside Breakout
finance.yahoo.com - May 11 at 5:47 PM
LLY Stock Approaching Support: Here Are Two Option Trade IdeasLLY Stock Approaching Support: Here Are Two Option Trade Ideas
finance.yahoo.com - May 11 at 5:47 PM
This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.